FDA Inspection 1181942 — Ethypharm
The FDA completed an inspection of Ethypharm on November 5, 2020 in Le Grand Quevilly CEDEX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- November 5, 2020
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Le Grand Quevilly CEDEX (France)
Additional Details
Mutual Recognition Agreement (MRA)